Antibodies against chemokine receptors CXCR3 and CXCR4 predict progressive deterioration of lung function in patients with systemic sclerosis
Abstract Background The chemokine receptors CXCR3 and CXCR4 are involved in the pathogenesis of fibrosis, a key feature of systemic sclerosis (SSc). It is hypothesized that immunoglobulin (Ig)G antibodies (abs) against these two receptors are present in patients with SSc and are associated with clin...
Main Authors: | Florian Weigold, Jeannine Günther, Moritz Pfeiffenberger, Otavio Cabral-Marques, Elise Siegert, Duska Dragun, Aurélie Philippe, Ann-Katrin Regensburger, Andreas Recke, Xinhua Yu, Frank Petersen, Rusan Catar, Robert Biesen, Falk Hiepe, Gerd R. Burmester, Harald Heidecke, Gabriela Riemekasten |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-03-01
|
Series: | Arthritis Research & Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13075-018-1545-8 |
Similar Items
-
Analysis of CXCR4 and ACKR3 oligomerisation
by: Heuninck, Joyce
Published: (2019) -
Impact of the Chemokine Receptors CXCR4 and CXCR7 on Clinical Outcome in Adrenocortical Carcinoma
by: Irina Chifu, et al.
Published: (2020-11-01) -
Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells
by: Heinrich Eileen L, et al.
Published: (2012-04-01) -
Differences in Sulfotyrosine Binding amongst CXCR1 and CXCR2 Chemokine Ligands
by: Natasha A. Moussouras, et al.
Published: (2017-09-01) -
Advances in CXCR7 Modulators
by: Nicole Lounsbury
Published: (2020-02-01)